RankingsPricing
  1. US-listed companies
  2. EyePoint Pharmaceuticals, Inc.

EyePoint Pharmaceuticals, Inc.EYPT

Market cap
$324.14M
P/E ratio
Back to summarized table
Income statementBalance sheetCash flow
Jun 30,
2012		Jun 30,
2013		Jun 30,
2014		Jun 30,
2015		Jun 30,
2016		Jun 30,
2017		Jun 30,
2018		Dec 31,
2019		Dec 31,
2020		Dec 31,
2021		Dec 31,
2022
Cash and cash equivalents571519151739224517996
Marketable securities1033914----3349
Accounts and other receivables, net11110001191816
Prepaid expenses and other current assets021101163410
Inventory-------2543
Total current assets161219303018404263238173
Property and equipment, net00000000101
Operating lease right-of-use assets-------3326
Intangible assets, net43321031282523-
Restricted cash--000000000
Total assets211623323219727392263180
Accounts payable01011134576
Accrued expenses1223444781416
Deferred revenue210000-0111
Short-Term Debt----------10
Other current liabilities--------111
Total current liabilities3323552212152435
Long-term debt------1747383729
Deferred Revenue, Noncurrent45666---161514
Operating Lease, Liability, Noncurrent-------3226
Other long-term liabilities------13221
Total liabilities79891156065737984
Preferred Stock, Value, Issued-----------
Common Stock, Value, Issued00000000000
Additional paid-in capital---293312323375473528753767
Accumulated deficit-252-264-277-271-292-311-364-465-511-569-671
Accumulated other comprehensive income11111111111
Total stockholders’ equity148152321131281918496
Total liabilities and stockholders’ equity211623323219727392263180